Genetic Technologies
Genetic Technologies Restructures Business to Reduce Cash Burn, Focus on US Growth
The firm's current CEO will also leave the company in September as a result of the changes.
In Brief This Week: DermTech, Devyser, Prenetics, Proteomics International, Genetic Technologies
News items for the week of June 17, 2024.
In Brief This Week: Labcorp; Revvity; BGI Genomics; Genetic Technologies; Revna Biosciences
News items for the week of April 25, 2024.
Genetic Technologies to Raise $2M in Direct Offering
The firm will offer 1 million American Depositary Shares, each representing 30 ordinary shares of the company's stock, at $2 per ADS.
Genetic Technologies Regains Compliance With Nasdaq Minimum Bid Price Requirement
The firm enacted a share consolidation and ADS ratio change in December and said on Friday that it has regained compliance with Nasdaq's minimum bid price rule.
Jul 21, 2023
Genetic Technologies Gets Nasdaq Delisting Warning
May 26, 2020
Genetic Technologies Prices $8M Public Offering
Apr 20, 2020